SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
OXiGENE Reports Data Showing Median Survival and One-Year Survival Improvement in Anaplastic Thyroid Cancer Patients Treated With ZYBRESTAT(R) and Chemotherapy